HUMBL Announces Corporate Rebrand to TAP Real Estate Technologies, Inc.

(Other OTC:HMBL),(OTC US:HMBL), Salt Lake City, UT, Dec. 31, 2025 (GLOBE NEWSWIRE) — HUMBL, Inc. (OTC: HMBL) today announced that it has initiated a strategic corporate rebrand to TAP Real Estate Technologies, Inc. (“TAP Real Estate”), reflecting the company's sharpened focus on real estate asset acquisition, ownership, and blockchain-enabled real estate tokenization. In connection with […]

STRIDE DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Stride, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – LRN

(NYSE:LRN), NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Stride, Inc. (NYSE: LRN) between October 22, 2024 and October 28, 2025, both dates inclusive (the “Class Period”), of the important January 12, 2026 lead plaintiff deadline. SO WHAT: If you

Marrelli Capital Limited Announces Changes to Holdings in BE Resources Inc.

TORONTO, Dec. 31, 2025 (GLOBE NEWSWIRE) — Carmelo Marrelli announces that he has filed an early warning report (the “Report“) announcing the disposition (the “Disposition“) of an aggregate of 7,609,176 common shares (the “Common Shares“) in the capital of BE Resources Inc. (the “Company“) to a third party pursuant to a share purchase agreement. Prior

Rio Silver Inc. Completes Securities for Debt Transaction

(TSX-V:RYO),(OTC US:RYOOF),(Other OTC:RYOOF), VANCOUVER, British Columbia, Dec. 31, 2025 (GLOBE NEWSWIRE) — Rio Silver Inc. (“Rio Silver” or the “Company“) is pleased to announce that it has settled an aggregate of $293,250 of indebtedness (the “Debts“) through (1) the issuance of an aggregate of 1,396,428 common shares of the Company at a deemed issuance price

Prime Drink Group Announces First Closing of Private Placement and Grant of Stock Options

(CNSX:PRME.CN), MONTREAL, Dec. 31, 2025 (GLOBE NEWSWIRE) — Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company“) announces a first closing of its previously announced non-brokered private placement offering of units of the Company (the “Unit Offering“) for gross proceeds of $450,000. As a result, the Company issued 7,500,015 common shares in the capital

Supermicro Unveils High-Density, Liquid-Cooled and Air-Cooled 6U SuperBlade® Powered by Intel® Xeon® 6900 Series Processors for Maximum Performance and Efficiency

— 6USuperBlade's innovative design delivers up to 93% cable reduction and 50% space savings compared to traditional 1U servers — 32-inch depth enclosure fits in a standard 19-inch rack, eliminating the need for a deep rack — Supports both air cooling (v 6U 5 nodes) and liquid cooling (6U 10 nodes) — Powered by dual

PharmaCorp Announces Grant of Stock Options

(TSX-V:PCRX), SASKATOON, Saskatchewan, Dec. 31, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation“) (TSXV: PCRX) has granted a total of 501,088 options to purchase common ‎shares to directors, officers, employees and consultants of the Corporation, with an exercise price of $0.46 and ‎an expiry date of December 31, 2035, subject to approval

North American Niobium and Critical Minerals Corp. Announces Marketing Agreement

(CNSX:NIOB),(CNSX:NIOB.CN),(Boerse Frankfurt – Freiverkehr:IOR),(OTC US:NIOMF),(Other OTC:NIOMF), Vancouver, BC, Dec. 31, 2025 (GLOBE NEWSWIRE) — North America Niobium and Critical Minerals Corp. (CSE: NIOB) (FSE: IOR) (OTCQB: NIOMF) (“North American Niobium” or the “Company”) is pleased to announce in accordance with CSE policies, that it has entered into a marketing agreement with an arm's length firm,

XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update

(TSX-V:XRTX),(NASDAQ:XRTX),(Boerse Frankfurt – Freiverkehr:ANUA.F), CALGARY, Alberta, Dec. 31, 2025 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company“) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, highlights recent peer-reviewed, independent, published research reports that expand current knowledge

SCULLY ROYALTY ANNOUNCEMENT

Scully Royalty Ltd. (the “Company”) (NYSE: SRL) announces it has published its half-year report, including its results for the six months ended June 30, 2025 which includes updates on the Company's business (the “Half-Year Report”). A copy of the Half-Year Report is available through the Company's website at www.scullyroyalty.comand is available under the Company's profile

Scroll to Top